Gyre Therapeutics (GYRE) EBIT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.21% |
| Dec 31, 2025 | -220.39% |
| Sep 30, 2025 | 218.98% |
| Jun 30, 2025 | -4.49% |
| Mar 31, 2025 | 241.80% |
| Dec 31, 2024 | -84.29% |
| Sep 30, 2024 | 32.53% |
| Jun 30, 2024 | -60.43% |
| Mar 31, 2024 | 108.81% |
| Dec 31, 2023 | -817.89% |
| Sep 30, 2023 | 156.61% |
| Jun 30, 2023 | -25.36% |
| Mar 31, 2023 | 129.67% |
| Dec 31, 2022 | -334.77% |
| Sep 30, 2022 | -110.03% |
| Jun 30, 2022 | 450.52% |
| Mar 31, 2022 | 27.63% |
| Dec 31, 2021 | 19.49% |
| Sep 30, 2021 | -26.69% |
| Jun 30, 2021 | 11.25% |
| Mar 31, 2021 | -19.09% |
| Dec 31, 2020 | -17.02% |
| Sep 30, 2020 | 7.26% |
| Jun 30, 2020 | -242.56% |
| Mar 31, 2020 | 63.77% |
| Dec 31, 2019 | -6.00% |
| Sep 30, 2019 | 8.25% |
| Jun 30, 2019 | 8.48% |
| Mar 31, 2019 | -34.49% |
| Dec 31, 2018 | -40.01% |
| Sep 30, 2018 | -17.30% |
| Jun 30, 2018 | -6.51% |
| Mar 31, 2018 | -14.58% |
| Dec 31, 2017 | 0.83% |
| Sep 30, 2017 | 1.11% |
| Jun 30, 2017 | -42.51% |
| Mar 31, 2017 | 20.10% |
| Dec 31, 2016 | 8.61% |
| Sep 30, 2016 | -16.22% |
| Jun 30, 2016 | -7.50% |
| Mar 31, 2016 | 2.37% |
| Dec 31, 2015 | -20.54% |
| Sep 30, 2015 | -76.51% |
| Jun 30, 2015 | 27.41% |
| Mar 31, 2015 | -68.63% |
| Dec 31, 2014 | -9.77% |
| Sep 30, 2014 | 25.88% |
| Jun 30, 2014 | -18.63% |
| Mar 31, 2014 | 86.00% |
| Dec 31, 2013 | -1.23% |
| Sep 30, 2013 | -5.27% |
| Jun 30, 2013 | -50.93% |
| Mar 31, 2013 | 49.11% |
| Dec 31, 2012 | -100.79% |
| Sep 30, 2012 | -156.89% |
| Jun 30, 2012 | 616.72% |
| Mar 31, 2012 | 119.58% |
| Dec 31, 2011 | -8.72% |
| Sep 30, 2011 | -262.93% |
| Jun 30, 2011 | -120.90% |
| Mar 31, 2011 | 1,006.56% |
| Dec 31, 2010 | -156.14% |
| Sep 30, 2010 | -51.33% |